The Recall Desk
SevereFDA (Drugs)·D-0396-2026·Announced 2026-03-11

Mojo Max Fusion capsules recalled as Class I over undeclared drug ingredients

Mojo Max Fusion XXX capsules are being recalled because FDA analysis revealed undeclared sildenafil at 13.1 mg per capsule and tadalafil at 13.8 mg per capsule. The FDA has classified this recall as Class I.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The rubric states an FDA Class I recall is never scored below 4, and this record carries a Class I classification with no reported deaths in the source.

Plain-English summary

Mohamed Hagar is recalling Mojo Max Fusion XXX, 500 mg, supplied as one capsule per blister card in 20-count boxes, distributed by Max Nutrition Inc., UPC 678945366750. About 125 boxes were distributed nationwide in the United States.

The product was marketed without an approved New Drug Application or Abbreviated New Drug Application, and FDA analysis revealed undeclared sildenafil at 13.1 mg per capsule and tadalafil at 13.8 mg per capsule. The FDA has classified this recall as Class I, its most serious category.

All lots are affected, with an expiry date of 12/31/2027.

Consumers can identify affected product by the UPC and expiry date above, and may contact the recalling firm for further information.

The recalled product

Product
Mojo Max Fusion XXX, 500 mg, one capsule per blister card, 20 count box, Distributed by: Max Nutrition Inc. UPC 6 78945 36675 0
Manufacturer
Mohamed Hagar
Category
Drug — Dietary supplement
Hazard
Affected units
125

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • ALL LOTS
  • exp 12/31/2027

Distribution

Distributed nationwide across the United States.

Related recalls

Same hazard · undeclared ingredient

See all →